This article analyzes recent market reactions to various financial instruments, highlighting potential investment opportunities and warnings across different sectors, from KKR to Global Atomic. Read more...

Novo Nordisk and Eli Lilly are battling it out in the weight-loss drug market with price cuts on Wegovy and Zepbound. Also, investment firms adjust their positions in KKR and Blue Owl. Read more...

Wall Street giants like KKR and Apollo are chasing Berkshire Hathaway's success while Kroger releases its Q4 2024 earnings. Plus, Eni and KKR finalize a major stake deal. Read more...